Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06479213 · ClinicalTrials.gov registry record · NA
REACH (Restore Energy, Activity Can Help) Lupus Study
A NA study of Fatigue and Systemic Lupus Erythematosus, sponsored by Tufts Medical Center.
- Active
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06479213: Active NA study of Fatigue and Systemic Lupus Erythematosus, sponsored by Tufts Medical Center.
NCT06479213 is a NA study of Fatigue and Systemic Lupus Erythematosus that is active but no longer recruiting, run by Tufts Medical Center. The registered enrollment target is 36 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06479213, a NA study of Fatigue and Systemic Lupus Erythematosus, is active but no longer recruiting, sponsored by Tufts Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to pilot test the REACH peer coaching program for fatigue in people with systemic lupus erythematosus. The main questions it aims to answer are: 1. Is the REACH program feasible and acceptable to participants? 2. What is the impact of the REACH program on fatigue? Researchers will compare the REACH peer coaching program to the REACH mobile health application to see if the REACH program works to reduce fatigue. Participants will: * Use the REACH mobile health application to set weekly movement goals and log daily physical activity * Meet weekly with their REACH peer coach (if they have one) to talk about their movement goals and progress * Complete weekly symptom surveys * Complete study surveys when they start the program, in the middle of the program, at the end of the program, and 12 weeks after the program ends * Participate in an interview to provide feedback on the program
Primary Outcome
Enrollment rates (subjects enrolled/eligible individuals approached).
Conditions Studied
Interventions
- BEHAVIORAL REACH Peer Coaching Program
- BEHAVIORAL REACH Mobile Health Application
Study Locations (1)
Massachusetts
- Tufts Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-06-13 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
What the registry record for NCT06479213 still lists
NCT06479213 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (83% lower).
The record links to 2 conditions, with Fatigue appearing as the primary indexed condition, and to 2 interventions - of which REACH Peer Coaching Program is the first listed.
NCT06479213 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06479213 about?
NCT06479213 is a clinical study titled "REACH (Restore Energy, Activity Can Help) Lupus Study". The goal of this clinical trial is to pilot test the REACH peer coaching program for fatigue in people with systemic lupus erythematosus. The main questions it aims to answer are: 1. Is the REACH program feasible and acceptable to participants? 2. What is the impact of the REACH program on fatigue?...
What is the current status of trial NCT06479213?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2024-06-13. Estimated completion is 2025-09-01.
What conditions does trial NCT06479213 study?
This clinical trial studies the following conditions: Fatigue, Systemic Lupus Erythematosus.
What interventions are being tested in trial NCT06479213?
The interventions under investigation include: REACH Peer Coaching Program (BEHAVIORAL), REACH Mobile Health Application (BEHAVIORAL).
Who is sponsoring clinical trial NCT06479213?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06479213 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fatigue
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06479213's enrollment target sits among peer trials
36 77th of 109 higher than 32 of 109 other Fatigue trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fatigue trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fatigue and Cognitive Demand With Aging
RECRUITING · NA
-
Behavioral and Neural Correlates of Post-Stroke Fatigue
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
The Fit With Us Study
RECRUITING · NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
RECRUITING · NA
-
Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI